19-45488954-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_005619.5(RTN2):​c.1274G>A​(p.Arg425Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000346 in 1,611,644 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R425P) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0017 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00021 ( 0 hom. )

Consequence

RTN2
NM_005619.5 missense

Scores

1
18

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.276

Publications

6 publications found
Variant links:
Genes affected
RTN2 (HGNC:10468): (reticulon 2) This gene belongs to the family of reticulon encoding genes. Reticulons are associated with the endoplasmic reticulum, and are involved in neuroendocrine secretion or in membrane trafficking in neuroendocrine cells. Reticulon proteins also play an important role in the replication of positive-strand RNA (ssRNA) viruses. Mutations at this locus have been associated with autosomal dominant spastic paraplegia-12. [provided by RefSeq, Aug 2020]
PPM1N (HGNC:26845): (protein phosphatase, Mg2+/Mn2+ dependent 1N (putative)) Predicted to enable metal ion binding activity and protein serine/threonine phosphatase activity. Predicted to be involved in negative regulation of I-kappaB kinase/NF-kappaB signaling and positive regulation of canonical Wnt signaling pathway. Predicted to be active in cytosol and nucleus. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0033495426).
BP6
Variant 19-45488954-C-T is Benign according to our data. Variant chr19-45488954-C-T is described in ClinVar as Benign. ClinVar VariationId is 448171.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00166 (252/152246) while in subpopulation AFR AF = 0.00537 (223/41562). AF 95% confidence interval is 0.00479. There are 2 homozygotes in GnomAd4. There are 123 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 2 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RTN2NM_005619.5 linkc.1274G>A p.Arg425Gln missense_variant Exon 7 of 11 ENST00000245923.9 NP_005610.1 O75298-1A8K7F2Q6GMT0
RTN2NM_206900.3 linkc.1055G>A p.Arg352Gln missense_variant Exon 6 of 10 NP_996783.1 O75298-2A8K7F2Q6GMT0
RTN2NM_206901.3 linkc.254G>A p.Arg85Gln missense_variant Exon 3 of 7 NP_996784.1 O75298-3A8K7F2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RTN2ENST00000245923.9 linkc.1274G>A p.Arg425Gln missense_variant Exon 7 of 11 1 NM_005619.5 ENSP00000245923.3 O75298-1

Frequencies

GnomAD3 genomes
AF:
0.00166
AC:
252
AN:
152128
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00538
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00157
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000588
Gnomad OTH
AF:
0.000479
GnomAD2 exomes
AF:
0.000435
AC:
106
AN:
243548
AF XY:
0.000402
show subpopulations
Gnomad AFR exome
AF:
0.00605
Gnomad AMR exome
AF:
0.000176
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000364
Gnomad OTH exome
AF:
0.000335
GnomAD4 exome
AF:
0.000209
AC:
305
AN:
1459398
Hom.:
0
Cov.:
33
AF XY:
0.000186
AC XY:
135
AN XY:
725732
show subpopulations
African (AFR)
AF:
0.00682
AC:
228
AN:
33438
American (AMR)
AF:
0.000225
AC:
10
AN:
44422
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26062
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39598
South Asian (SAS)
AF:
0.0000117
AC:
1
AN:
85632
European-Finnish (FIN)
AF:
0.0000188
AC:
1
AN:
53138
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5746
European-Non Finnish (NFE)
AF:
0.0000459
AC:
51
AN:
1111076
Other (OTH)
AF:
0.000232
AC:
14
AN:
60286
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.489
Heterozygous variant carriers
0
21
42
64
85
106
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00166
AC:
252
AN:
152246
Hom.:
2
Cov.:
32
AF XY:
0.00165
AC XY:
123
AN XY:
74426
show subpopulations
African (AFR)
AF:
0.00537
AC:
223
AN:
41562
American (AMR)
AF:
0.00157
AC:
24
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5162
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4818
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0000588
AC:
4
AN:
68008
Other (OTH)
AF:
0.000474
AC:
1
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
13
26
38
51
64
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
4
8
12
16
20
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000554
Hom.:
2
Bravo
AF:
0.00192
ESP6500AA
AF:
0.00635
AC:
28
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000503
AC:
61
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spastic paraplegia Benign:1
Nov 27, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Aug 31, 2016
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.079
BayesDel_addAF
Benign
-0.56
T
BayesDel_noAF
Benign
-0.58
CADD
Benign
12
DANN
Uncertain
1.0
DEOGEN2
Benign
0.061
T;.;T;.
Eigen
Benign
-0.82
Eigen_PC
Benign
-0.68
FATHMM_MKL
Benign
0.036
N
LIST_S2
Benign
0.78
T;T;T;T
M_CAP
Benign
0.0044
T
MetaRNN
Benign
0.0033
T;T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
-0.040
N;.;.;.
PhyloP100
-0.28
PrimateAI
Benign
0.35
T
PROVEAN
Benign
1.4
N;N;.;N
REVEL
Benign
0.040
Sift
Benign
0.27
T;T;.;T
Sift4G
Benign
0.86
T;T;T;T
Polyphen
0.17
B;.;.;B
Vest4
0.11
MVP
0.043
MPC
0.32
ClinPred
0.019
T
GERP RS
1.0
PromoterAI
0.0070
Neutral
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.067
gMVP
0.32
Mutation Taster
=90/10
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs35461805; hg19: chr19-45992212; API